Video

"User-friendly" Levodopa, Advancing Treatment, and Teaching Parkinson's Disease

Author(s):

Norika Malhado-Chang, MD, assistant professor of Neurology at University of California at Davis, discusses how progress in Parkinson's disease and movement disorders is changing the scope of comprehensive care, addressing non-motor symptoms, and supplying tools for the next generation of neurology specialists.

Norika Malhado-Chang, MD, teaches clinical neurology for 3rd- and 4th-year medical students at the University of California at Davis. That responsibility on the assistant professor of Neurology compounds when one considers the great changes of perspective, product, and procedure that have come into the fields of Parkinson's diseas and movement disorders as of late.

At the 21st International Congress of Parkinson's Disease and Movement Disorders in Vancouver, BC, Malhado-Chang discussed advocacy for comprehensive care, improving the safety and efficacy of treatment staple levodopa, and helping shape the future generation of Parkinson's disease specialists.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
© 2025 MJH Life Sciences

All rights reserved.